Entries by Su, Ally
(中文) 鼎康生物与翰思艾泰达成合作项目，加速赋能创新药物上市进程
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 鼎康生物公布获得瑞伏医疗健康基金1740万美元投资，持续保持收入双位数增长
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 年度大奖｜鼎康生物荣膺“TOP CDMO IN APAC 2022”
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 喜讯|鼎康生物成功入选“2022中国潜在独角兽”企业！
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 为什么商业化制剂生产要找鼎康生物？
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 鼎康生物在德国成立欧洲商务中心，拓宽航道推进欧洲市场布局
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 坚守“疫”线 ，全力以赴保生产
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
(中文) 喜讯！鼎康生物荣获大中华区最佳生物制品CMO企业
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.